High-risk of recurrence for nodal micrometastasis with breast pathologic complete response (ypT0/Tis ypN1mi) after neoadjuvant chemotherapy.

被引:0
|
作者
Garcia Torralba, Esmeralda
de la Morena, Pilar
Garcia Gomez, Marina
Ivars Rubio, Alejandra
Garcia Martinez, Elena
Garcia-Garre, Elisa
Martinez Galvez, Maria
Marin Zafra, Gema
Aguilar Jimenez, Jose
Navarro Manzano, Esther
Ayala, Francisco
机构
[1] Hosp G Univ Morales Meseguer, Dept Hematol & Med Oncol, IMIB Arrixaca, Murcia, Spain
[2] Univ Murcia, Murcia, Spain
[3] Hosp G Univ Morales Meseguer, Dept Radiol, Murcia, Spain
[4] Hosp G Univ Morales Meseguer, Dept Surg, UMU, IMIB Arrixaca, Murcia, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e12524
引用
收藏
页数:2
相关论文
共 50 条
  • [1] PATHOLOGIC COMPLETE RESPONSE (YPT0 YPN0) AFTER CHEMOTHERAPY AND RADIOTHERAPY NEOADJUVANT FOLLOWED BY ESOPHAGECTOMY IN THE SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS
    Andreollo, Nelson Adami
    Beraldo, Giovanni de Carvalho
    Filardi Alves, Iuri Pedreira
    Tercioti-Junior, Valdir
    Possato Ferrer, Jose Antonio
    Coelho-Neto, Joao de Souza
    Lopes, Luiz Roberto
    [J]. ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2018, 31 (04):
  • [2] Survival and recurrence of breast cancer patients with pathologic complete response after neoadjuvant chemotherapy.
    Lee, Young Joo
    Ahn, Sei-Hyun
    Sohn, Byung Ho
    Lee, Jong Won
    Chung, Il Yong
    Ko, Beom Seok
    Kim, Hee Jeong
    Kim, Jisun
    Lee, Sae Byul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] COMPLETE PATHOLOGICAL RESPONSE AFTER NEOADJUVANT THERAPY IN RECTAL CANCER: DOES YPT0 ALSO MEAN YPN0?
    Shankar, B.
    Raghunath, R.
    Jesudason, M.
    [J]. DISEASES OF THE COLON & RECTUM, 2017, 60 (06) : E104 - E105
  • [4] Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery
    Pfob, Andre
    Sidey-Gibbons, Chris
    Rauch, Geraldine
    Thomas, Bettina
    Schaefgen, Benedikt
    Kuemmel, Sherko
    Reimer, Toralf
    Hahn, Markus
    Thill, Marc
    Blohmer, Jens-Uwe
    Hackmann, John
    Malter, Wolfram
    Bekes, Inga
    Friedrichs, Kay
    Wojcinski, Sebastian
    Joos, Sylvie
    Paepke, Stefan
    Degenhardt, Tom
    Rom, Joachim
    Rody, Achim
    van Mackelenbergh, Marion
    Banys-Paluchowski, Maggie
    Grosse, Regina
    Reinisch, Mattea
    Karsten, Maria
    Golatta, Michael
    Heil, Joerg
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (17) : 1903 - +
  • [5] Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
    M Tanioka
    C Shimizu
    K Yonemori
    K Yoshimura
    K Tamura
    T Kouno
    M Ando
    N Katsumata
    H Tsuda
    T Kinoshita
    Y Fujiwara
    [J]. British Journal of Cancer, 2010, 103 : 297 - 302
  • [6] Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
    Tanioka, M.
    Shimizu, C.
    Yonemori, K.
    Yoshimura, K.
    Tamura, K.
    Kouno, T.
    Ando, M.
    Katsumata, N.
    Tsuda, H.
    Kinoshita, T.
    Fujiwara, Y.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 103 (03) : 297 - 302
  • [7] Pathologic complete response is an independent prognostic factor for locoregional recurrence in locally advanced breast cancer patients after neoadjuvant chemotherapy.
    Chou, Hsu-Huan
    Chen, Shin-Che
    [J]. MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 65 - 66
  • [8] Determinants of pathological complete response and tumor regression in high-risk breast cancer treated with neoadjuvant radiotherapy and chemotherapy.
    Haussmann, Jan
    Budach, Wilfried
    Kraemling, Carolin Nestle
    Wollandt, Sylvia
    Jazmati, Danny
    Tamaskovics, Balint
    Corradini, Stefanie
    Boelke, Edwin
    Haussmann, Alexander
    Audretsch, Werner
    Matuschek, Christiane
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Risk of locoregional and distant recurrence in patients achieving a pathologic complete in-breast response after neoadjuvant chemotherapy for breast cancer
    Krug, D.
    Hauswald, H.
    Aigner, J.
    Heil, J.
    Schneeweiss, A.
    Debus, J.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 79 - 79
  • [10] Pathologic Complete Response to Neoadjuvant Chemotherapy and Pembrolizumab in Postpartum High-Risk Basal-Type Breast Cancer
    Jiang, Heng
    Cartwright, Sara
    Wagner, David G.
    Krishnamurthy, Jairam
    Santamaria-Barria, Juan A.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)